“Good Things Come in Small Packets” - Nanotechnology A Boon in the Treatment of Cardiovascular Diseases

Imran Rashid Rangraze

Department of Internal Medicine, RAKMHSU, RAK, UAE

Dr. Imran Rashid Rangraze, Department of Internal Medicine, RAKMHSU, RAK, UAE.

Keywords: Nanotechnology; Nanoparticles; Cardiovascular Diseases

Abstract

Cardiovascular diseases (CVD) are the major cause of mortality and morbidity in both developing and developed countries. It represents 31% of global deaths, that constitutes a sizeable chunk of overall mortality. Conventional treatment of CVDs can only cure the symptoms but cannot repair the damaged or ischemic tissues; hence new therapeutic approaches are desperately waranted.
Nanotechnology represents one such approach. It involves the use of materials on an atomic, molecular, and supra molecular level (on the scale of 10-150 nanometers), for the purpose of not only diagnosing and treating cardiovascular diseases but also repairing damaged tissues in biological systems. It is a novel method that has shown great promise in dealing with cardiovascular complications.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).